Virginia Retirement Systems Et Al Bridge Bio Pharma, Inc. Transaction History
Virginia Retirement Systems Et Al
- $15 Billion
- Q3 2025
A detailed history of Virginia Retirement Systems Et Al transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 10,500 shares of BBIO stock, worth $590,730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,500
Previous 5,300
98.11%
Holding current value
$590,730
Previous $228,000
139.04%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
413Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.04 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$927 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$746 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$700 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$522 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.34B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...